aap Implantate Future Growth

Future criteria checks 1/6

aap Implantate is forecast to grow earnings and revenue by 44.4% and 11% per annum respectively. EPS is expected to grow by 48% per annum. Return on equity is forecast to be -11.7% in 3 years.

Key information

44.4%

Earnings growth rate

48.0%

EPS growth rate

Medical Equipment earnings growth18.3%
Revenue growth rate11.0%
Future return on equity-11.7%
Analyst coverage

Low

Last updated18 Jan 2024

Recent future growth updates

Recent updates

Investors Give aap Implantate AG (ETR:AAQ1) Shares A 26% Hiding

Jun 15
Investors Give aap Implantate AG (ETR:AAQ1) Shares A 26% Hiding

One Analyst Just Shaved Their aap Implantate AG (ETR:AAQ1) Forecasts Dramatically

Aug 20
One Analyst Just Shaved Their aap Implantate AG (ETR:AAQ1) Forecasts Dramatically

Is aap Implantate (ETR:AAQ1) Weighed On By Its Debt Load?

Apr 04
Is aap Implantate (ETR:AAQ1) Weighed On By Its Debt Load?

Here's Why aap Implantate (ETR:AAQ1) Can Afford Some Debt

Dec 06
Here's Why aap Implantate (ETR:AAQ1) Can Afford Some Debt

Is aap Implantate (ETR:AAQ1) Using Too Much Debt?

Aug 23
Is aap Implantate (ETR:AAQ1) Using Too Much Debt?

aap Implantate (ETR:AAQ1) Is Carrying A Fair Bit Of Debt

May 10
aap Implantate (ETR:AAQ1) Is Carrying A Fair Bit Of Debt

Earnings and Revenue Growth Forecasts

XTRA:AAQ1 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202617N/AN/AN/A1
12/31/202515-1001
12/31/202413-2-2-21
12/31/202311-4-3-21
6/30/202312-2-2-2N/A
3/31/202312-2-2-2N/A
12/31/202212-3-2-2N/A
9/30/202211-3-3-3N/A
6/30/202211-4-4-3N/A
3/31/202212-3-4-3N/A
12/31/202112-3-3-2N/A
9/30/202112-3-3-2N/A
6/30/202112-4-3-2N/A
3/31/202111-6-3-3N/A
12/31/20209-9-4-4N/A
9/30/202010-15-5-5N/A
6/30/202011-21-7-6N/A
3/31/202011-21-8-6N/A
12/31/201913-19-7-6N/A
9/30/201913-14-8-6N/A
6/30/201913-8-8-5N/A
3/31/201914-7-7-5N/A
12/31/201813-8-9-6N/A
9/30/201813-8-7-5N/A
6/30/201813-8-7-5N/A
3/31/201812-9-7-6N/A
12/31/201712-9-7-5N/A
9/30/201711-9-6-7N/A
6/30/201711-9-6-6N/A
3/31/201713-9N/A-6N/A
12/31/201612-9N/A-7N/A
9/30/201613-11N/A-5N/A
6/30/201614-11N/A-3N/A
3/31/201614-10N/A-5N/A
12/31/201514-10N/A-2N/A
9/30/20155-12N/A-3N/A
6/30/20159-10N/A-5N/A
3/31/201514-7N/A-2N/A
12/31/201417-6N/A-3N/A
9/30/2014330N/A-1N/A
6/30/2014310N/A-2N/A
3/31/201430-1N/A4N/A
12/31/2013331N/A4N/A
9/30/2013211N/A3N/A
6/30/2013251N/A6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AAQ1 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AAQ1 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AAQ1 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AAQ1's revenue (11% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: AAQ1's revenue (11% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AAQ1 is forecast to be unprofitable in 3 years.


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.